深度绑定国际巨头，双轮驱动收入提速，医用护理垫隐形冠军爱舍伦上市在即

Core Viewpoint - The article emphasizes the importance of disposable medical consumables in modern healthcare, highlighting the leading position of Jiangsu Aisheren Medical Technology Group Co., Ltd. in this sector, driven by innovation and quality manufacturing [1][2]. Group 1: Company Overview - Jiangsu Aisheren was established in 2015, with roots tracing back to 2003, focusing on rehabilitation care and medical infection control [2]. - The company has developed a diverse product matrix, including medical care pads, ice bags, surgical gowns, and surgical kits, serving various healthcare settings [2]. - Aisheren has become one of the top ten exporters of medical dressings in China, with multiple production bases both domestically and internationally [3]. Group 2: Innovation and Competitive Advantage - Aisheren has built a strong competitive edge through process and product innovations, achieving full automation in production processes, which reduces reliance on manual labor and enhances efficiency [2][3]. - The company has upgraded its core products using composite technology, significantly improving physical strength and comfort, with specific products achieving high load capacities and moisture permeability [3]. Group 3: Market Position and Client Relationships - Aisheren has established a robust quality management system and has received multiple international certifications, making it a core supplier for major global brands like Medline and Zarys International Group [4][5]. - The company operates on an ODM/OEM business model, actively participating in product design and development, which strengthens client relationships and enhances product offerings [5]. Group 4: Financial Performance - Aisheren's revenue has shown rapid growth, with 2024 revenue projected at 6.92 billion yuan, a 20.56% increase from the previous year, and a significant rise in net profit [6][8]. - The company’s main business gross margin has remained stable between 22% and 23%, indicating strong cost control and product competitiveness [11]. Group 5: Market Demand and Future Prospects - The global medical dressing market is expected to grow from $9 billion in 2011 to $23.5 billion by 2026, driven by aging populations and increased healthcare standards [13][20]. - Aisheren plans to raise 300 million yuan for expanding production capacity and optimizing its product structure, aiming to enhance its product matrix with high-value items [21][22].